In the September period CL reported disappointing results. The overall sales were of 3.85 billion and earning of 0.60 per share.
For the 2019 we belive that the company, with strategic actions in effective pricing, product innovations and cost reduction should lead a better performance in this year.
Earning per share in 2019 could reach 3.05 $ with a total sales...
Colgate-Palmolive CL Short Opportunity Risk/Reward Ratio 2.25
On the weekly chart we see the powerful downtrend
and we see a reversal on daily chart
Risk/Reward Ratio 2.25
Entry 63.22
Stop Loss 64.86
Take Profits 59.5
Waiting for retracement at around $67. There is confluence of
- Triangle trendline support,
- 50MA,
- Key Fibo level
- Golden Cross
- All 3 key indicators are also bullish
Will execute only with Bullish Pinbar on support. Look out for updates..
There is no complicated science here.
The trend is your friend until its broken.
The major trend right now is down and it just broke the short-term bounce-back so it's a good time to SELL with a small position size, there is plenty of room down towards the support line.
CL looks good.
I really like the weekly chart even though the trend lines are under the cloud.
The stock is oversold.
Indicators are turning up.
Looking for a few points moving into earnings.
Position: 3000 SHARES
PURCHASE PRICE: $65.80
I'm in NYSE:CL at $62.00.
It counts with everything i look for in a swing trade.
Positive RSI and MACD about to crossover = Bullish.
I plan on taking profits at +- $68.
It somewhat a value play, due to that i believe the stock is very cheap right now.
Share your opinion, comments and questions. Good Luck!
Risk Level: Low - Moderate.
I will keep updating my...
From our last analysis on September this share has dropped a lot, and we think that now is oversold. It remain a possibile target for a mega-merger and the target price could be between 85,00 and 95,00 dollars per share.
Suitable for conservative investors, dominat global position, steady dividend,
Dividend yeld @ 2.72%.
Total debt: 6.5 billions,
Annual...
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
CLS
